ตารางพิกัดอัตราศุลกากร คำวินิจฉัย D-Memoranda มาตรการแก้ไขทางการค้า ข้อกำหนด PGA ระบอบคว่ำบาตร

Heading 3002

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified.

10 subheadings

หัวข้อย่อย

3002.12

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: - Antisera and other blood fractions

6 tariff items

3002.13

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: - Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

1 tariff items

3002.14

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: - Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale

1 tariff items

3002.15

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: - Immunological products, put up in measured doses or in forms or packings for retail sale

1 tariff items

3002.41

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: - Vaccines for human medicine

2 tariff items

3002.42

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: - Vaccines for veterinary medicine

2 tariff items

3002.49

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: - Other

3 tariff items

3002.51

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Cell cultures, whether or not modified: - Cell therapy products

1 tariff items

3002.59

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Cell cultures, whether or not modified: - Other

1 tariff items

3002.90

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Other

4 tariff items

คำวินิจฉัยล่วงหน้าที่เกี่ยวข้อง

บันทึกอธิบาย

Section 11 of the Customs Tariff states that in interpreting the headings and subheadings, regard shall be had to the World Customs Organization's (WCO) Compendium of Classification Opinions and Explanatory Notes to the Harmonized Commodity Description and Coding System (HS). General Interpretative Rule 1 (GIR 1) directs that titles of Sections, Chapters and sub-Chapters are provided for ease...

Source: advance_ruling (8000003182)

However, the Explanatory Notes to the heading state that diagnostic kits having the essential character of products of heading 30.02 or 30.06 (e.g., those based on monoclonal or polyclonal antibodies) are excluded. Heading 30.02 includes immunological products. The Explanatory Note to heading 30.02 states, “Diagnostic kits are classified here when the essential character of the kit is given by...

Source: advance_ruling (C-2017-010225)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products

Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)

Antisera and other blood fractions This subheading covers the products described in the HS Explanatory Note to heading 3002 , (C), (1), second and third paragraph. This subheading includes ‘normal’ sera, plasma, fibrinogen, fibrin and, provided that it is prepared for therapeutic or prophylactic uses, blood albumin (for example, obtained by fractionating the plasma of human blood). Blood...

Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)

Immunological products and Other These subheadings cover the products described in the HS Explanatory Notes to heading 3002 (C), (2).

Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)

Vaccines for human medicine For the interpretation of the term ‘vaccines’, see the HS Explanatory Note to heading 3002 , (D), (1).

Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)

Vaccines for veterinary medicine See the explanatory note to subheading 3002 20 00 .

Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)

Cultures of micro-organisms See the HS Explanatory Note to heading 3002 , (D), (3).

Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)

Other This subheading includes toxins and, in so far as they are ‘similar products’, the symbiotic parasites used to treat certain diseases, such asPlasmodium(the malarial parasite) andTrypanosoma cruzi.

Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)

30.04 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. 3004.50.00 -Other medicaments containing vitamins or other products of heading 29.36. 27. There are no relevant...

Source: citt_decision (AP-2009-017)

Chapter 30 Notes (4)
1. 1. This Chapter does not cover: • (a) Foods or beverages (such as dietetic, diabetic or fortified foods, food supplements, tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV); • (b) Products, such as tablets, chewing gum or patches (transdermal systems), containing nicotine and intended to assist tobacco use cessation (heading 24.04); • (c) Plasters specially calcined or finely ground for use in dentistry (heading 25.20); •...
2. 2. For the purposes of heading 30.02, the expression “immunological products” applies to peptides and proteins (other than goods of heading 29.37) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody garment conjugates, interleukins, interferons (IFN), chemokines and certain tumor necrosis factors (TNF), growth factors (GF), hematopoietins and colony stimulating factors (CSF).
3. 3. For the purpose of headings 30.03 and 30.04 and of Note 4 (d) to this Chapter, the following are to be treated: • (a) As unmixed products: (1) Unmixed products dissolved in water; (2) All goods of Chapter 28 or 29; and (3) Simple vegetable extracts of heading 13.02, merely standardised or dissolved in any solvent; • (b) As products which have been mixed: (1) Colloidal solutions and suspensions (other than colloidal sulphur); (2) Vegetable extracts obtained by the treatment of mixtures of...
4. 4. Heading 30.06 applies only to the following, which are to be classified in that heading and in no other heading of the Nomenclature: • (a) Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; • (b) Sterile laminaria and sterile laminaria tents; • (c) Sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable;...

พร้อมจำแนกพิกัดได้เร็วขึ้นหรือยัง?

CustomsLogIQ ใช้ข้อมูลพิกัดอัตราศุลกากรนี้เพื่อขับเคลื่อนการจำแนกพิกัดด้วย AI ทดลองใช้ฟรี

ทดลองใช้ CustomsLogIQ ฟรี